These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 35038132)
21. SURF-COPD: the recording of cardiovascular risk in patients with chronic lung disease. Dudina A; Lane S; Butler M; Cooney MT; Graham I QJM; 2018 May; 111(5):303-306. PubMed ID: 29432601 [TBL] [Abstract][Full Text] [Related]
23. Impact of cancers and cardiovascular diseases in chronic obstructive pulmonary disease. Sin DD; Man SF Curr Opin Pulm Med; 2008 Mar; 14(2):115-21. PubMed ID: 18303420 [TBL] [Abstract][Full Text] [Related]
24. The natural history of chronic obstructive pulmonary disease. Mannino DM; Watt G; Hole D; Gillis C; Hart C; McConnachie A; Davey Smith G; Upton M; Hawthorne V; Sin DD; Man SF; Van Eeden S; Mapel DW; Vestbo J Eur Respir J; 2006 Mar; 27(3):627-43. PubMed ID: 16507865 [TBL] [Abstract][Full Text] [Related]
25. Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study. Gale NS; Albarrati AM; Munnery MM; Mcdonnell BJ; Benson VS; Singer RMT; Cockcroft JR; Shale DJ Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987061 [No Abstract] [Full Text] [Related]
26. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease. Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245 [TBL] [Abstract][Full Text] [Related]
27. The effect of reducing the number of cigarettes smoked on risk of lung cancer, COPD, cardiovascular disease and FEV(1)--a review. Lee PN Regul Toxicol Pharmacol; 2013 Dec; 67(3):372-81. PubMed ID: 24013038 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk in chronic obstructive pulmonary disease. Maclay JD; McAllister DA; Macnee W Respirology; 2007 Sep; 12(5):634-41. PubMed ID: 17875049 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment. Wood-Baker R; Cochrane B; Naughton MT Intern Med J; 2010 Feb; 40(2):94-101. PubMed ID: 19849745 [TBL] [Abstract][Full Text] [Related]
30. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Curkendall SM; DeLuise C; Jones JK; Lanes S; Stang MR; Goehring E; She D Ann Epidemiol; 2006 Jan; 16(1):63-70. PubMed ID: 16039877 [TBL] [Abstract][Full Text] [Related]
31. Early cardiovascular involvement in chronic obstructive pulmonary disease. Malerba M; Romanelli G Monaldi Arch Chest Dis; 2009 Jun; 71(2):59-65. PubMed ID: 19719036 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan. Onishi K; Yoshimoto D; Hagan GW; Jones PW Int J Chron Obstruct Pulmon Dis; 2014; 9():563-8. PubMed ID: 24920894 [TBL] [Abstract][Full Text] [Related]
33. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease. Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402 [TBL] [Abstract][Full Text] [Related]
34. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer. Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444 [TBL] [Abstract][Full Text] [Related]